As President, Global R&D Design and Delivery Innovation, Dr. Cynthia Verst is responsible for overseeing the world’s largest contract research organization with operations that span the clinical development continuum at IQVIA.
With more than 20 years of biopharmaceutical industry experience, Dr. Verst has a proven track record of operational excellence and innovation amidst an increasingly complex healthcare environment. Before being appointed as President of Clinical Operations in 2015, she served as President of Real-World & Late Phase Research at IQVIA. In 2014, Dr. Verst was named one of the top women in biotech by FierceBiotech, an annual award that spotlights an elite list of 15 women leaders in the life sciences, academia and regulatory roles.
Prior to joining IQVIA, she served as Senior Vice President, Global Late Phase Research, for OptumInsight (a division of UnitedHealth Group, formerly i3), where she and her team successfully established a new global Late Phase Research Business Unit. Dr. Verst began her career in biopharma at Procter & Gamble Pharmaceuticals as section head in its North American Medical and Technical Affairs group, successfully leading the Phase IIIB/IV research requirements of marketed products.
Dr. Verst holds a Pharm.D. and bachelor’s degree in pharmacy from the University of Cincinnati, a master’s degree in structural and cellular biology from the University of Illinois, and bachelor’s degrees in biology and chemistry from Northern Kentucky University.